Skip to main content
SpringerLink
Log in

Antigen-Specific Therapy for Autoimmune Disease: Prospects for the Prevention of Insulin-Dependent Diabetes

  • Minireview
  • Published:
Molecular Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Harrison LC. (1992) Islet cell autoantigens in insulin-dependent diabetes: Pandora’s box revisited. Immunol. Today 13: 348–352.

    Article  CAS  PubMed  Google Scholar 

  2. Paul WE. (1993) Fundamental Immunology. 3rd Ed. Raven Press, New York.

    Google Scholar 

  3. Kikutani H, Makino AS. (1992) The murine autoimmune diabetes model: NOD and related strains. Adv. Immunol. 51: 282–322.

    Google Scholar 

  4. Zhang ZH, Davidson L, Eisenbath G, Weiner HL. (1991) Suppression of diabetes in nonobese diabetic mice by oral administration of 726 porcine insulin. Proc. Natl. Acad. Sci. U.S.A. 88: 10252–10256.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Tisch R, Yang X-D, Singer SM, et al. (1993) Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature 366: 72–75.

    Article  CAS  PubMed  Google Scholar 

  6. Kaufman DL, Clare-Salzler M, Tian J, et al. (1993) Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 366: 69–72.

    Article  CAS  PubMed  Google Scholar 

  7. Petersen JS, Karlsen AE, Markholst H, et al. (1994) Neonatal tolerisation with glutamic acid decarboxylase but not with bovine serum albumin delays the onset of diabetes in NOD mice. Diabetes 44: 1478–1484.

    Article  Google Scholar 

  8. Wells H. (1911) Studies on the chemistry of anaphylaxis. III. Experiments with isolated proteins, especially those of the hen’s egg. J. Infect. 9: 147–151.

    Article  CAS  Google Scholar 

  9. Critchfield JM, Lenardo MJ. (1995) Antigen-induced programmed T cell death as a new approach to immune therapy. Clin. Immunol. Immunopathol. 75: 13–19.

    Article  CAS  PubMed  Google Scholar 

  10. Burstein HJ, Shea CM, Abbas AK. (1992) Aqueous antigens induce in vivo tolerance selectively in IL-2- and IFN-γ-producing (Thl) cells. J. Immunol. 148: 3687–3691.

    PubMed  CAS  Google Scholar 

  11. Evavold BD, Sloan-Lancaster J, Allen PM. (1993) Tickling the TCR: Selective T-cell functions stimulated by altered peptide ligands. Immunol. Today 14: 602–609.

    Article  CAS  PubMed  Google Scholar 

  12. Johnson JG, Jenkins MK. (1994) The role of anergy in peripheral T cell unresponsiveness. Life Sci. 55: 1767–1780.

    Article  CAS  PubMed  Google Scholar 

  13. Weiner HL, Friedman A, Miller A, et al. (1994) Oral tolerance: Immunologic mechanism and treatment of animal and human organ-specific autoimmune disease by oral administration of autoantigens. Annu. Rev. Immunol. 12: 809–837.

    Article  CAS  PubMed  Google Scholar 

  14. Lombardi G, Sidhu S, Batchelor R, Lechler R. (1994) Anergic T cells as suppressor cells in vitro. Science 264: 1587–1589.

    Article  CAS  PubMed  Google Scholar 

  15. Atkinson M, Maclaren N, Luchetta R. (1990) Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapy. Diabetes 39: 933–937.

    Article  CAS  PubMed  Google Scholar 

  16. Gotfredsen CF, Buschard K, Frandsen EK. (1985) Reduction of diabetes incidence of BB Wistar rats by early prophylactic insulin treatment of diabetes-prone animals. Diabetologia 28: 933–935.

    Article  CAS  PubMed  Google Scholar 

  17. Muir A, Peck A, Clare-Salzler M, et al. (1995) Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-γ transcription. J. Clin. Invest. 95: 628–634.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Wegmann DR, Gill RG, Norbury-Glaser M, Schloot N, Daniel D. (1994) Analysis of the spontaneous T cell response to insulin in NOD mice. J. Autoimmun. 7: 833–843.

    Article  CAS  PubMed  Google Scholar 

  19. Harrison LC, Dempsey-Collier M. (1994) Autoantigen-specific suppression of diabetes development in non-obese diabetic (NOD) mice. Proc. Aust. Diab. Soc. Abstr. 79, p. 73.

  20. Palmer JP, Asplin CM, Clemons P, et al. (1983) Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 222: 1337–1339.

    Article  CAS  PubMed  Google Scholar 

  21. Harrison LC, Chu XS, DeAizpurua HJ, Graham M, Honeyman MC, Colman PG. (1992) Islet-reactive T cells are a marker of preclinical insulin-dependent diabetes. J. Clin. Invest. 89: 1161–1165.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. DeAizpurua HJ, Wilson Y, Harrison LC. (1992) Glutamic acid decarboxylase (GAD) autoantibodies in pre-clinical insulin-dependent diabetes. Proc. Natl. Acad. Sci. U.S.A. 89: 9841–9845.

    Article  CAS  Google Scholar 

  23. Honeyman MC, Cram DS, Harrison LC. (1993) Glutamic acid decarboxylase 67-reactive T cells: A marker of insulin-dependent diabetes. J. Exp. Med. 177: 535–540.

    Article  CAS  PubMed  Google Scholar 

  24. Bingley PJ, Bonifacio E, Gale EAM. (1993) Can we really predict IDDMM? Diabetes 42: 213–220.

    Article  CAS  PubMed  Google Scholar 

  25. Keller RJ, Jackson RA, Eisenbarth GS. (1993) Insulin prophylaxis in individuals at high risk for the development of type 1 diabetes mellitus. Lancet 341: 927–928.

    Article  CAS  PubMed  Google Scholar 

  26. Weiner HL, Mackin GA, Matsui M, et al. (1993) Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis. Science 259: 1321–1324.

    Article  CAS  PubMed  Google Scholar 

  27. Trentham DA, Dynesius-Trentham RA, Orav EJ, et al. (1993) Effects of oral administration of type II collagen on rheumatoid arthritis. Science 261: 1727–1730.

    Article  CAS  PubMed  Google Scholar 

  28. Husby S, Mestecky J, Moldoveanu Z, et al. (1994) Oral tolerance in humans. J. Immunol. 152: 4663–4670.

    PubMed  CAS  Google Scholar 

  29. Metzler B, Wraith DC. (1993) Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: Influence of MHC binding affinity. Int. Immunol. 5: 1159–1165.

    Article  CAS  PubMed  Google Scholar 

  30. Waldo FB, Van Den Wallbake AWL, Mestecky J, Husby S. (1994) Suppression of the immune response by nasal immunization. Clin. Immunol. Immunopathol. 72: 30–34.

    Article  CAS  PubMed  Google Scholar 

  31. Rudy G, Brusic V, Harrison LC, Lew AM. (in press) Sequence similarity between β-cell autoantigens. Immunol. Today.

  32. Rudy G, Stone N, Harrison LC, et al. (1995) Similar peptides from two beta cell autoantigens, proinsulin and glutamic acid decarboxylase, stimulate T cells of individuals at risk for insulin-dependent diabetes. Mol. Med. 1: 625–633.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Woodyatt RT. (1923) The clinical use of insulin. J. Metab. Res. 2: 793–801.

    Google Scholar 

  34. Gizurarson S, Bechgaard E. (1991) Intranasal administration of insulin to humans. Diab. Res. Clin. Prac. 12: 71–84.

    Article  CAS  Google Scholar 

Download references

Acknowledgments

I thank Drs. Margo Honeyman, Andrew Lew, and George Rudy for their comments and Mrs. Margaret Thompson for secretarial assistance.

Author information

Authors and Affiliations

  1. The Walter and Eliza Hall Institute of Medical Research, Royal Melbourne Hospital, Parkville, Victoria, Australia

    Leonard C. Harrison

Authors
  1. Leonard C. Harrison
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Harrison, L.C. Antigen-Specific Therapy for Autoimmune Disease: Prospects for the Prevention of Insulin-Dependent Diabetes. Mol Med 1, 722–727 (1995). https://doi.org/10.1007/BF03401887

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03401887

Search

Navigation